[1] ZHANG M X. The studies on the anti-Alzheimer′s disease fraction of acorus tatarinowii and its preliminary material basis [D]. Shanghai: China State Institute of Pharmaceutical Industry, 2016.
[2] LU Y N. The main data of the Seventh National population Census announced that the total population maintained steady growth [N]. People′s Daily, 2021-05-12(1).
[3] JIA L, DU Y, CHU L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study[J]. Lancet Public Health, 2020, 5(12):e661-e671.
[4] KWON Y. Luteolin as a potential preventive and therapeutic candidate for Alzheimer′s disease [J]. Exp Gerontol, 2017, 95:39-43.
[5] MARTIN R R,DE M L,AMBROSONE A, et al. Targeted nanoparticles for the treatment of Alzheimer′s disease [J]. Curr Pharm Des, 2017, 23(13):1927-1952.
[6] LV Y M. Study of donepezil hydrochloride dispersible tablets [D]. Tianjin: Tianjin Medical University, 2017.
[7] WANG Q Q, LV J L, HU Y C, et al. Pathogenesis and new therapeutic drugs of Alzheimer disease [J]. Chin Pharm J(中国药学杂志), 2020, 55(23):1939-1947.
[8] ZHANG X L, ZENG J W, CHEN X, et al. Comparison and interpretation of Chinese and British guidelines about therapeutic drugs for Alzheimer′s disease [J]. Chin Gen Pract(中国全科医学), 2021, 24(12): 1454-1458.
[9] GUO Y B, SHI J M, LIU H, et al. Research progress of amyloid β peptide as a drug target for Alzheimer′s disease [J]. Chin J Anat(解剖学杂志), 2021, 44(3): 242-246.
[10] TOLAR M, ABUSHAKRA S, HEY J A, et al. Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer′s disease with potential for near term approval [J]. Alzheimers Res Ther, 2020, 12(1):95.
[11] GUO Q Q, CHU E G, ZHONG Z G. Mechanism of traditional Chinese and western medicine research and treatment of senile dementia [J]. Asia-Pac Trad Med(亚太传统医药), 2015, 11(13): 41-44.
[12] LI Y X.Bioavailability of single oral dose of galanthamine hydrobromide extended-release pellet capsule in dogs [J].J China Pharm(中国药房), 2009, 20(4): 261-262.
[13] SANCHEZ L E, ETTCHETO M, EGEA M A, et al. New potential strategies for Alzheimer′s disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9 [J]. Nanomedicine, 2017, 13(3): 1171-1182.
[14] CHEN Z M, LONG X Y. Research progress of different drug delivery routes in microparticle drug delivery system [J]. J Guangdong Pharm Univ(广东药学院学报), 2007,(6): 686-690.
[15] QU Y D. Studies on the palliative effect of deproteinized calf blood extractives iniection on Alzheimer′s disease [D]. Changchun: Jilin University, 2019.
[16] MA Y,XU R N. Study on the preparation technology of nimodipine freeze-dried powder injection [J]. Sci Technol Inf(科技信息),2007(26): 70-72.
[17] LIU S K. Study on galanthamine long-acting sustained-release microsphere injection: China, 2009102302927[P]. 20131001.
[18] CAI X Q. Studies on polymer thermogel of huperzine A [D]. Jinan: Shandong University, 2012.
[19] XIANG N X, ZHANG Y, HE X Y, et al. Preparation and pharmacokinetic study of huperzine A phospholipid in situ-gel [J]. West China J Pharm Sci(华西药学杂志), 2017, 32(2): 143-146.
[20] DONG H Y, ZHANG H, SHUAI Z F, et al. Effects of β-asarone and tenuigenin on activities of SOD, GSH, CAT, MDA and HO-1 in APP/PS1 double transgenic mice [J]. Nat Prod Res Dev(天然产物研究与开发), 2017, 29(9): 1551-1557.
[21] SIAFAKA P I, BULBUL E O, MUTLU G, et al. Transdermal drug delivery systems and their potential in Alzheimer′s disease management [J]. CNS Neurol Disord Drug Targets. 2020, 19(5): 360-373.
[22] ZHANG Z X, HONG Z, WANG Y P, et al. Rivastigmine patch in Chinese patients with probable Alzheimer′s disease: A 24-week, randomized, double-blind parallel-group study comparing rivastigmine patch (9.5 mg/24 h) with capsule (6 mg twice daily) [J]. CNS Neurosci Ther, 2016, 22(6): 488-496.
[23] SALUJA S, KASHA PC, PATURI J, et al. A novel electronic skin patch for delivery and pharmacokinetic evaluation of donepezil following transdermal iontophoresis [J]. Int J Pharm, 2013, 453(2): 395-399.
[24] WANG J S, WANG W Q, WANG C G, et al. Advances in studies on transdermal patch of Chinese materia medica [J]. Chin Tradit Herb Drugs(中草药), 2012, 43(5): 1028-1031.
[25] CUI Y, GUO J, ZHANG L.Microemulsion and its application in different ways of drug administration [J]. J China Pharm(中国药房), 2010, 21(25): 2390-2393.
[26] SHI J, CONG W, WANG Y, et al. Microemulsion-based patch for transdermal delivery of huperzine A and ligustrazine phosphate in treatment of Alzheimer′s disease [J]. Drug Dev Ind Pharm, 2012, 38(6): 752-761.
[27] ZHU H M, LIU T, HE Q R, et al. Research progress of transdermal gel of traditional Chinese medicine [J]. Chin Tradit Pat Med(中成药), 2018, 40(8): 1811-1814.
[28] WOO F Y, BASRI M, MASOUMI H R, et al. Formulation optimization of galantamine hydrobromide loaded gel drug reservoirs in transdermal patch for Alzheimer′s disease [J]. Int J Nanomed, 2015, 10: 3879-3886.
[29] MENDES I T, RUELA A L M, CARVALHO F C, et al. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil [J]. Colloids Surf B Biointerfaces, 2019, 177: 274-281.
[30] SETYA S, MADAAN T, RAZDAN BK, et al. Design and development of novel transdermal nanoemulgel for Alzheimer′s disease: pharmacokinetic, pharmacodynamic and biochemical investigations [J]. Curr Drug Deliv, 2019, 16(10): 902-912.
[31] NGUYEN T T, PARK J H. Human studies with microneedles for evaluation of their efficacy and safety [J]. Expert Opin Drug Deliv, 2018, 15(3): 235-245.
[32] WEI W, ZHAO F, MA Y L, et al. Research progress of nanodrug delivery system based on microneedles [J]. Chin Pharm J(中国药学杂志), 2021, 56(10): 785-789.
[33] YAN Q, WANG W, WENG J, et al. Dissolving microneedles for transdermal delivery of Huperzine A for the treatment of Alzheimer′s disease [J]. Drug Deliv, 2020, 27(1): 1147-1155.
[34] SONG L L. Study on the preparation technology and quality of donepezil hydrochloride tablets [D]. Jinan: Shandong University, 2016.
[35] KIM J Y, HAN M R, KIM Y H, et al. Tip-loaded dissolving microneedles for transdermal delivery of donepezil hydrochloride for treatment of Alzheimer′s disease [J]. Eur J Pharm Biopharm, 2016, 105: 148-155.
[36] KEARNEY M C, CAFFAREL S E, FALLOWS S J, et al. Microneedle-mediated delivery of donepezil: Potential for improved treatment options inAlzheimer′s disease [J]. Eur J Pharm Biopharm, 2016, 103: 43-50.
[37] BAHADUR S, SACHAN N, HARWANSH R K, et al. Nanoparticlized system: promising approach for the management of Alzheimer′s disease through intranasal delivery [J]. Curr Pharm Des, 2020, 26(12): 1331-1344.
[38] SUN Y, LI L, XIE H, et al. Primary studies on construction and evaluation of ion-sensitive in situ gel loaded with paeonol-solid lipid nanoparticles for intranasal drug delivery [J]. Int J Nanomed, 2020, 15: 3137-3160.
[39] XIANG Y, LONGY, TAN Y J, et al. Application of new dosage forms and new techniques in nasal and cerebral targeted drug delivery system of effective components of traditional Chinese medicine [J]. Chin Tradit Pat Med(中成药), 2020, 42(4): 991-995.
[40] CHEN X M.Experimental study on pharmacodynamics of Ginsenoside Rg1 nasal spray [J]. Chin J Exp Tradit Med Form(中国实验方剂学杂志), 2011, 17(10): 219-222.
[41] CHEN X M.Effect of dosage form and administration route to distribution of Ginsenoside Rg1 in serum and brain of rats [J]. Chin J Exp Tradit Med Form(中国实验方剂学杂志), 2011, 17(14): 43-46.
[42] XU X P, PAI Y F, HUANG Z J, et al. Preparation of nimodipine nanoemulsion for intranasal delivery and preliminary studies on its brain tissue targeting [J]. Chin Pharm J(中国药学杂志), 2012, 47(8): 594-598.
[43] CHEN G. Studies on huperzine a microemulsion temperature/pH-sensitive in situ gel for nasal delievery [D]. Hefei: Anhui University of Chinese Medicine, 2016.
[44] XU R X. Process, quality evaluation and rat brain targeting study of Shenqing nasal microemulsion [D]. Guangzhou: Guangzhou University of Chinese Medicine, 2013.
[45] ESPINOZA LC, VACACELA M, CLARES B, et al. Development of a nasal donepezil-loaded microemulsion for the treatment of Alzheimer′s disease: in vitro and ex vivo characterization [J]. CNS Neurol Disord Drug Targets, 2018, 17(1): 43-53.
[46] VIEIRA D B, GAMARRA L F. Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier [J]. Int J Nanomed, 2016, 11: 5381-5414.
[47] ROSS C, TAYLOR M, FULLWOOD N, et al. Liposome delivery systems for the treatment of Alzheimer′s disease [J]. Int J Nanomed, 2018, 13: 8507-8522.
[48] AL ASMARI A K, ULLAH Z, TARIQ M, et al. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil [J]. Drug Des Devel Ther, 2016, 10: 205-215.
[49] TAN Y Z. Study on drug delivery system of H102 peptide loaded PEG-PLGA nanoparticles [D].Tianjin: Tianjin Medical University, 2013.
[50] ZHENG X, SHAO X, ZHANG C, et al. Intranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer′s disease [J]. Pharm Res, 2015, 32(12): 3837-3849.
[51] SHAO Y X.Development of nasal spray of H102 peptide to treat Alzheimer′s disease [D]. Shanghai: Fudan University, 2013.
[52] TAN Y Z, SHAO Y X, CHEN J, et al. Preparation, characteristic and in vivo study of H102 loaded PEG-PLGA nanoparticles [J]. Chin Pharm J(中国药学杂志), 2014, 49(3): 216-220.
[53] JIANG Y Y. The design of lactoferrin loaded HupAnanoemulsion and research of brain targeting mechanism via intranasal route [D]. Changchun: Jilin University, 2020.
[54] MUNTIMADUGU E, DHOMMATI R, JAIN A, et al. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer′s disease [J]. Eur J Pharm Sci, 2016, 92: 224-234.
[55] ELNAGGAR Y S R, ETMAN S M, ABDELMONSIF D A, et al. Intranasal Piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer′s disease: optimization, biological efficacy, and potential toxicity [J]. J Pharm Sci, 2015, 104(10): 3544-3556.
[56] CHEN Y, CHENG G, HU R, et al. A nasal temperature and pH dual-responsive in situ gel delivery system based on microemulsion of huperzine A: formulation, evaluation, and in vivo pharmacokinetic study [J]. AAPS Pharm Sci Tech, 2019, 20(7): 301.
[57] GU F G, FAN H M, CONG Z X, et al. Preparation, characterization, and in vivo pharmacokinetics of thermosensitive in situ nasal gel of donepezil hydrochloride [J]. Acta Pharm, 2020, 70(3): 411-422.